62 participants
FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-12-20
- Start Date:
- 2024-06-01
- Completion:
- 2026-06-01
Conditions
- Non-small Cell Lung Cancer
Interventions
- COMBINATION_PRODUCT
No Results Yet